A study reported that PD-L2 expression is upregulated in tumour-associated macrophages (TAM), and its inhibitory effects become evident when PD-L1 function is abrogated by anti-PD-L1 monoclonal antibody (mAb) [17]. Here, PDCD1LG2 is linked to neoplasm.